About this trial
The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.
Eligibility criteria
Qualifiers
Age from 40 to 80 years old, either gender;
Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
Willing to undergo second eye surgery within 7 days after first eye surgery;
The potential postoperative visual acuity of 20/40 or better in both eyes;
Disqualifiers
Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;
Preexisting systemic diseases or conditions that may confound the results of the study;
Previous ocular surgery history or ocular trauma that may confound the results of the study;
Require combined surgery that may confound the results of the study;
Trial design
Treatments tested in this trial
- SN6AD1
- SBL-3
- LS-313 MF30
- AT LISA tri 839 MP
- ART
- LS-313 MF30T
Treatment groups
6
Treatment groupsSee each treatment group below.